CXCL8 and metabolic dysfunction-associated steatohepatitis: In the liver, this cytokine was reported to promote the progression from steatosis to non‐alcoholic steatohepatitis (NASH) by upregulating the expression of hepatocyte‐derived IL‐8 and chemokine CXCL1 to recruit neutrophils [95, 96, 97].